Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Sandlund

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Leukemia|June 1, 1996
Prognostic factors in the acute lymphoid and myeloid leukemias of infantsC H Pui, R C Ribeiro, D Campana, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2014
Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginaseC A Fernandez, E Stewart, J C Panetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Sex differences in prognosis for children with acute lymphoblastic leukemiaC H Pui, J M Boyett, M V Relling, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Cancer|December 18, 2001
Second malignancy after treatment of childhood non-Hodgkin lymphomaW Leung, J T Sandlund, M M Hudson, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Leukemia|May 1, 1997
Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern BrazilJ T Sandlund, T Fonseca, T Leimig, et al.
Leukemia|October 17, 2008
Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemiaJ R Roberson, H L Spraker, J Shelso, et al.
The New England Journal of Medicine|June 19, 1997
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemiaC H Pui, J M Boyett, W T Hughes, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Leukemia|June 1, 1996
Prognostic factors in the acute lymphoid and myeloid leukemias of infantsC H Pui, R C Ribeiro, D Campana, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2014
Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginaseC A Fernandez, E Stewart, J C Panetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Sex differences in prognosis for children with acute lymphoblastic leukemiaC H Pui, J M Boyett, M V Relling, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Cancer|December 18, 2001
Second malignancy after treatment of childhood non-Hodgkin lymphomaW Leung, J T Sandlund, M M Hudson, et al.
Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.
Leukemia|February 26, 2004
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapseE Coustan-Smith, A Gajjar, N Hijiya, et al.
Leukemia|May 1, 1997
Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern BrazilJ T Sandlund, T Fonseca, T Leimig, et al.
Leukemia|October 17, 2008
Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemiaJ R Roberson, H L Spraker, J Shelso, et al.
The New England Journal of Medicine|June 19, 1997
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemiaC H Pui, J M Boyett, W T Hughes, et al.
Pageof 12